BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38382769)

  • 1. Impact of dry coating lactose as a brittle excipient on multi-component blend processability.
    Lin Z; Cabello B; Davé RN
    Int J Pharm; 2024 Mar; 653():123921. PubMed ID: 38382769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Fine API Agglomeration After Dry Coating for Enhanced Blend Uniformity and Processability of Low Drug Loaded Blends.
    Kim SS; Castillo C; Sayedahmed M; Davé RN
    Pharm Res; 2022 Dec; 39(12):3155-3174. PubMed ID: 35882741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface engineered excipients: III. Facilitating direct compaction tableting of binary blends containing fine cohesive poorly-compactable APIs.
    Chen L; He Z; Kunnath KT; Fan S; Wei Y; Ding X; Zheng K; Davé RN
    Int J Pharm; 2019 Feb; 557():354-365. PubMed ID: 30597273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Silica Dry Coprocessing with API and Blend Mixing Time on Blend Flowability and Drug Content Uniformity.
    Kim SS; Seetahal A; Amores N; Kossor C; Davé RN
    J Pharm Sci; 2023 Aug; 112(8):2124-2136. PubMed ID: 37230252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitating direct compaction tableting of fine cohesive APIs using dry coated fine excipients: Effect of the excipient size and amount of coated silica.
    Lin Z; Cabello B; Kossor C; Davé R
    Int J Pharm; 2024 Jun; 660():124359. PubMed ID: 38901539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
    Kunnath K; Huang Z; Chen L; Zheng K; Davé R
    Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced blend uniformity and flowability of low drug loaded fine API blends via dry coating: The effect of mixing time and excipient size.
    Kim SS; Castillo C; Cheikhali M; Darweesh H; Kossor C; Davé RN
    Int J Pharm; 2023 Mar; 635():122722. PubMed ID: 36796658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine grade engineered microcrystalline cellulose excipients for direct compaction: Assessing suitability of different dry coating processes.
    Chen L; He Z; Kunnath K; Zheng K; Kim S; Davé RN
    Eur J Pharm Sci; 2020 Aug; 151():105408. PubMed ID: 32502519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight Into a Novel Strategy for the Design of Tablet Formulations Intended for Direct Compression.
    Capece M; Huang Z; Davé R
    J Pharm Sci; 2017 Jun; 106(6):1608-1617. PubMed ID: 28283431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface engineered excipients: II. Simultaneous milling and dry coating for preparation of fine-grade microcrystalline cellulose with enhanced properties.
    Chen L; Ding X; He Z; Fan S; Kunnath KT; Zheng K; Davé RN
    Int J Pharm; 2018 Jul; 546(1-2):125-136. PubMed ID: 29763689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface engineered excipients: I. improved functional properties of fine grade microcrystalline cellulose.
    Chen L; Ding X; He Z; Huang Z; Kunnath KT; Zheng K; Davé RN
    Int J Pharm; 2018 Jan; 536(1):127-137. PubMed ID: 29191481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving blend content uniformity via dry particle coating of micronized drug powders.
    Huang Z; Xiong W; Kunnath K; Bhaumik S; Davé RN
    Eur J Pharm Sci; 2017 Jun; 104():344-355. PubMed ID: 28435077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of Silica Type and Amount for Flowability Enhancements via Dry Coating: Contact Mechanics Based Predictive Approach.
    Kunnath KT; Tripathi S; Kim SS; Chen L; Zheng K; Davé RN
    Pharm Res; 2023 Dec; 40(12):2917-2933. PubMed ID: 37468827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding Fine API Agglomeration as a Key Indicator of Powder Flowability and Dissolution: Impact of Particle Engineering.
    Kim S; Cheikhali M; Davé RN
    Pharm Res; 2022 Dec; 39(12):3079-3098. PubMed ID: 35698012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry coating of micronized API powders for improved dissolution of directly compacted tablets with high drug loading.
    Han X; Ghoroi C; Davé R
    Int J Pharm; 2013 Feb; 442(1-2):74-85. PubMed ID: 22921376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression.
    Hirschberg C; Sun CC; Rantanen J
    J Pharm Biomed Anal; 2016 Sep; 128():462-468. PubMed ID: 27368089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of flow and bulk density of pharmaceutical powders using surface modification.
    Jallo LJ; Ghoroi C; Gurumurthy L; Patel U; Davé RN
    Int J Pharm; 2012 Feb; 423(2):213-25. PubMed ID: 22197769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-step Coprocessing of Cohesive Powder via Mechanical Dry Coating for Direct Tablet Compression.
    Qu L; Stewart PJ; Hapgood KP; Lakio S; Morton DAV; Zhou QT
    J Pharm Sci; 2017 Jan; 106(1):159-167. PubMed ID: 27665128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of agglomerated directly compressible diluent consisting of brittle and ductile materials.
    Gohel MC; Jogani PD; Bariya SE
    Pharm Dev Technol; 2003; 8(2):143-51. PubMed ID: 12760565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.